N-(3-{[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-1H-imidazo[4,5-c]pyridin-6-yl]oxy}phenyl)-4-[2-(4-morpholinyl)ethoxy]benzamide(CAS: 850664-21-0)

The compound is crystalline at room temperature with a molecular weight of approximately 750 g/mol. It has a high solubility in polar solvents like dimethylformamide (DMF) and acetonitrile. Chemically, it is stable under neutral conditions but can react with strong acids or bases. It shows reactivity towards nucleophiles, potentially undergoing substitution reactions.

This compound is synthesized via a multistep process involving the condensation of a 1-ethyl-1H-imidazo[4,5-c]pyridin-6-yl-2-(4-amino-1,2,5-oxadiazol-3-yl) derivative with a morpholine derivative. Key reagents include acetic anhydride, dicyclohexylcarbodiimide (DCC), and triethylamine (TEA). The overall yield is around 70%, with good selectivity for the desired product.

This compound is primarily used in the pharmaceutical industry due to its biological activity. It has potential applications in drug discovery and development, particularly in the treatment of cancer and inflammation. It may also have uses in sensor technology and as a semiconductor material in electronic devices.

Handling this compound should be done in a well-ventilated area with appropriate personal protective equipment (PPE), including gloves, goggles, and a lab coat. It should be stored in a cool, dry place away from direct sunlight and heat sources. In case of a spill, it should be cleaned up using appropriate absorbent materials. Always refer to the Safety Data Sheet (SDS) for detailed handling and disposal instructions.